HealthEquity (NASDAQ:HQY) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of HealthEquity (NASDAQ:HQY) from a hold rating to a buy rating in a research note issued to investors on Saturday morning.

Other equities analysts also recently issued reports about the stock. UBS Group set a $110.00 price objective on shares of HealthEquity in a research note on Tuesday, February 17th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research note on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, March 19th. KeyCorp increased their price objective on shares of HealthEquity from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, January 8th. Finally, BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $111.79.

HealthEquity Price Performance

Shares of HQY stock opened at $79.91 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.27 and a quick ratio of 3.27. The company has a market capitalization of $6.75 billion, a P/E ratio of 32.48, a P/E/G ratio of 1.42 and a beta of 0.26. The company’s 50-day simple moving average is $79.52 and its two-hundred day simple moving average is $88.78. HealthEquity has a one year low of $72.76 and a one year high of $116.65.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The business had revenue of $334.59 million for the quarter, compared to the consensus estimate of $332.48 million. HealthEquity’s quarterly revenue was up 7.3% compared to the same quarter last year. As a group, equities analysts anticipate that HealthEquity will post 2.32 EPS for the current year.

Institutional Investors Weigh In On HealthEquity

Several institutional investors have recently bought and sold shares of the company. Xponance Inc. boosted its stake in HealthEquity by 0.8% in the third quarter. Xponance Inc. now owns 12,265 shares of the company’s stock valued at $1,162,000 after acquiring an additional 102 shares in the last quarter. Truist Financial Corp boosted its stake in HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after acquiring an additional 119 shares in the last quarter. Fiduciary Trust Co boosted its stake in HealthEquity by 3.4% in the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after acquiring an additional 120 shares in the last quarter. Larson Financial Group LLC boosted its stake in HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in HealthEquity by 59.3% in the third quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock valued at $37,000 after acquiring an additional 146 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.